CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigator Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
35,156 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0658

Super Shred

Filed under Injectable Oils. The bureau holds 136 laboratory returns for this compound from 62 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

62 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
Tianjin Finder Chemical TFCCASE #VI-2026-0693 A 4 10.0 9.9 10.0 14 Nov 2025 16 Apr 2026
WuXi TIDESCASE #VI-2026-0335 A 3 10.0 10.0 10.0 3 Feb 2026 6 Jul 2026
Sigma-AldrichCASE #VI-2026-0829 A 3 10.0 10.0 10.0 2 Jul 2026 15 Aug 2026
PolyPeptide GroupCASE #VI-2026-0143 A 3 10.0 9.9 10.0 5 Jan 2026 14 Aug 2026
AmbioPharmCASE #VI-2026-0177 A 3 10.0 9.9 10.0 12 Feb 2026 6 Jun 2026
JEEP PeptidesCASE #VI-2026-0457 A 2 10.0 10.0 10.0 5 Dec 2025 1 Jul 2026
Kerui PeptidesCASE #VI-2026-0626 A 2 10.0 10.0 10.0 4 Jun 2026 19 Jun 2026
Mokemei BiotechnologyCASE #VI-2026-0540 A 2 10.0 10.0 10.0 14 Dec 2025 15 Apr 2026
HomopeptideCASE #VI-2026-0760 A 4 9.9 9.9 10.0 24 May 2026 24 May 2026
Hubei JianxiangCASE #VI-2026-0048 A 4 9.9 9.9 10.0 7 Feb 2026 11 Jul 2026
Shanghai Sigma AudleyCASE #VI-2026-0505 A 4 9.9 9.9 10.0 4 Mar 2026 2 Jul 2026
Hybio PharmaceuticalCASE #VI-2026-0065 A 4 9.9 9.9 10.0 22 Mar 2026 10 Aug 2026
SinoPepCASE #VI-2026-0387 A 4 9.9 9.9 10.0 18 Apr 2026 15 Jul 2026
AsymchemCASE #VI-2026-0091 A 4 9.9 9.9 10.0 20 Apr 2026 5 Jul 2026
Flourishglobal PeptideCASE #VI-2026-0630 A 3 9.9 9.9 9.9 8 May 2026 2 Jul 2026
Chinese Peptide CompanyCASE #VI-2026-0184 A 3 9.9 9.9 10.0 1 Apr 2026 21 May 2026
Thermo Fisher ScientificCASE #VI-2026-0142 A 3 9.9 9.9 10.0 5 Mar 2026 4 Aug 2026
Shanghai ERP BiotechnologyCASE #VI-2026-0936 A 2 9.9 9.9 10.0 7 Jan 2026 3 Jul 2026
Sangon BioCASE #VI-2026-0671 A 2 9.9 9.9 10.0 3 Apr 2026 5 Jul 2026
QYAOBIOCASE #VI-2026-0861 A 2 9.9 9.9 10.0 6 May 2026 9 Jul 2026
BachemCASE #VI-2026-0314 A 2 9.9 9.9 10.0 2 Dec 2025 4 Jan 2026
Shanghai Wibson BiotechnologyCASE #VI-2026-0379 A 2 9.9 9.9 9.9 27 Apr 2026 11 Jul 2026
GenScript PeptidesCASE #VI-2026-0860 A 2 9.9 9.9 10.0 8 Mar 2026 4 Aug 2026
Lux Synth AminosCASE #VI-2026-0700 X 1 9.9 9.9 9.9 7 May 2025 7 May 2025
Orbitrex PeptidesCASE #VI-2026-0812 X 1 9.8 9.8 9.8 14 Jan 2025 14 Jan 2025
Hunan GoodPeptides Biotech CoCASE #VI-2026-0370 X 1 9.3 9.3 9.3 13 Feb 2025 13 Feb 2025
Atomik LabzCASE #VI-2026-0327 X 2 9.2 8.5 10.0 21 May 2025 21 May 2026
Peptronix Bio PTBCASE #VI-2026-0979 X 1 9.1 9.1 9.1 3 Jul 2025 3 Jul 2025
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 A 8 9.0 6.5 10.0 23 May 2026 23 May 2026
Shanghai Sigma Audley SSACASE #VI-2026-0486 A 3 8.9 8.6 9.4 21 May 2026 21 May 2026
Zhang TYCASE #VI-2026-0070 X 1 8.5 8.5 8.5 2 Jul 2025 2 Jul 2025
Mix PeptidesCASE #VI-2026-0699 X 1 8.5 8.5 8.5 21 May 2025 21 May 2025
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 A 4 8.2 7.3 8.6 21 May 2026 21 May 2026
Qingdao Sigma Chemical QSCCASE #VI-2026-0538 A 2 8.2 8.1 8.4 24 May 2026 24 May 2026
Bfflist AMOCASE #VI-2026-0678 X 4 8.1 6.9 8.9 3 Jul 2025 24 May 2026
EHZ PeptidesCASE #VI-2026-0296 C 3 8.0 6.8 9.9 20 Jun 2025 21 May 2026
Glbiochem (Shanghai)CASE #VI-2026-0704 A 4 7.9 7.4 8.8 23 May 2026 23 May 2026
NextGen HealthCASE #VI-2026-0604 X 1 7.9 7.9 7.9 11 Jun 2025 11 Jun 2025
AKS ChemCASE #VI-2026-0313 X 1 7.7 7.7 7.7 17 Dec 2024 17 Dec 2024
Aavant ResearchCASE #VI-2026-0831 X 1 7.2 7.2 7.2 7 May 2025 7 May 2025
Zhejiang Yichenkang BiotechnologyCASE #VI-2026-0269 X 1 7.0 7.0 7.0 21 May 2025 21 May 2025
Shandong Aishi BiotechnologyCASE #VI-2026-0308 X 3 6.9 6.2 7.6 13 Jun 2025 25 May 2026
PeptidologyCASE #VI-2026-0520 X 1 6.9 6.9 6.9 3 Jun 2025 3 Jun 2025
Evolve BioPepCASE #VI-2026-0755 X 1 6.9 6.9 6.9 13 Jun 2025 13 Jun 2025
Verified PeptidesCASE #VI-2026-0407 X 2 6.7 5.4 8.0 13 Feb 2025 23 May 2026
Xianhong Tong XHT PeptidesCASE #VI-2026-0997 X 1 6.7 6.7 6.7 2 Jul 2025 2 Jul 2025
ZhuoYan labCASE #VI-2026-0902 X 3 6.2 4.0 9.2 2 Jul 2025 17 May 2026
Huaian Hanyou PeptideCASE #VI-2026-0297 X 1 6.2 6.2 6.2 20 Jun 2025 20 Jun 2025
Regenerative ResearchCASE #VI-2026-0349 X 1 6.1 6.1 6.1 11 Jun 2025 11 Jun 2025
OupeptideCASE #VI-2026-0435 X 2 5.8 4.7 6.8 11 Jun 2025 24 May 2026
HXNetCASE #VI-2026-0061 X 2 5.8 5.1 6.4 8 Jul 2025 19 Jan 2026
Kerisite Shenzhen InternationalCASE #VI-2026-0315 X 1 5.8 5.8 5.8 16 Mar 2025 16 Mar 2025
Bulk Peptide SupplyCASE #VI-2026-0446 X 1 5.8 5.8 5.8 3 Jun 2025 3 Jun 2025
LN PeptidesCASE #VI-2026-0781 X 2 5.6 5.2 6.0 28 Mar 2025 24 May 2026
Shandong Shengyuan Peptide TechnologyCASE #VI-2026-0634 X 1 5.5 5.5 5.5 28 Mar 2025 28 Mar 2025
Oasis PeptidesCASE #VI-2026-0404 X 1 5.3 5.3 5.3 28 Mar 2025 28 Mar 2025
Xingtai Lesda TechnologyCASE #VI-2026-0381 X 1 5.2 5.2 5.2 2 Jul 2025 2 Jul 2025
DeuschemCASE #VI-2026-0004 X 1 4.8 4.8 4.8 21 May 2025 21 May 2025
UWA Elite PeptidesCASE #VI-2026-0130 X 1 4.1 4.1 4.1 25 Apr 2025 25 Apr 2025
Biolongevity LabsCASE #VI-2026-0442 X 1 3.8 3.8 3.8 25 Apr 2025 25 Apr 2025
Coastal PeptidesCASE #VI-2026-0958 X 1 3.1 3.1 3.1 2 Jul 2025 2 Jul 2025
Guangzhou Yuao TradingCASE #VI-2026-0787 X 1 0.0 0.0 0.0 9 Jun 2025 9 Jun 2025

Open any subject to view the batch-level evidence for Super Shred alone.